View Post

HITAP developing book to highlight best buys, wasted buys and controversies in non-communicable diseases prevention

By Rachel Archer Dec. 14, 2018

With Universal Health Coverage (UHC) Day 2018 only just been and gone, the HITAP team are already gearing up for next year’s UHC Day – when we plan to launch a book detailing best buys, wasted buys and controversies in the prevention of non-communicable diseases (NCDs). The burden of NCDs remains high in low and middle-income countries (LMICs). Reducing this …

Prof Jo Lord and Dr Kalipso Chalikidou visit Ghana to continue work on optimising hypertension care pathway

By Kalipso Chalkidou , Prof. Jo Lord Apr. 6, 2017

The Global Health and Development group at Imperial College London (formerly NICE International) has worked with the Ghanaian authorities, under the leadership of the country’s Ministry of Health for a number of years, with support from the UK’s Department for International Development and more recently the Rockefeller Foundation and PATH under ADP. Since the last visit in April 2016 at which …

Off-Label Use of Drugs and Access to Medicines for All: A Thailand Example – Asia Unbound blog

Susie Colville Feb. 11, 2016

Yanzhong Huang’s blog, Off-Label Use of Drugs and Access to Medicines for All: A Thailand Example, reflects on the role of off-label drugs for improving affordable access to innovative medicines and facilitating progress towards UHC, highlighting the Thai experience of bevacizumab. “up to 68 percent of out of pocket health costs in resource-limited countries is for medication… inclusion of off-label drugs in the UHC …